Mark Yarchoan

Also affiliated with Johns Hopkins University, Johns Hopkins Medicine, Sidney Kimmel Cancer Center, Convergence, Johns Hopkins Hospital, Sidney Kimmel Comprehensive Cancer Center, University of Baltimore

MedicineImmunology and Microbiology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

1in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Papers

Driven by 43 papers. Top paper: “Profiling of syngeneic mouse HCC tumor models as a framework to understand anti–PD‐1 sensitive tumor microenvironments”.

Profiling of syngeneic mouse HCC tumor models as a framework to understand anti–PD‐1 sensitive tumor microenvironments

Hepatology(2022)10.1002/hep.32707

N/A

2.5DataRank · unranked

64 citations

Ludmila Danilova, James M. Leatherman, Tamara Y. Lopez‐Vidal, Jessica I. Sanchez, Soren Charmsaz +15 more

Multicenter randomized phase II trial of atezolizumab with or without cobimetinib in biliary tract cancers

Journal of Clinical Investigation(2021)10.1172/jci152670

N/A

2.1DataRank · unranked

86 citations

Leslie Cope, Amanda N. Ruggieri, Robert A. Anders, Anne M. Noonan, Laura W. Goff +24 more

Pathological response following neoadjuvant immune checkpoint inhibitors in patients with hepatocellular carcinoma: a cross-trial, patient-level analysis

The Lancet Oncology(2024)10.1016/s1470-2045(24)00457-1

N/A

1.7DataRank · unranked

70 citations

Bernardo Stefanini, Julia Blanter, Benjamin Adegbite, Fionnuala Crowley, Vincent Yip +18 more

Systemic inhibition of PTPN22 augments anticancer immunity

Journal of Clinical Investigation(2021)10.1172/jci146950

N/A

1.3DataRank · unranked

55 citations

Sarah Croessmann, Jianping Lin, Zaw Phyo, Soren Charmsaz, Ludmila Danilova +18 more

Virtual clinical trials of anti-PD-1 and anti-CTLA-4 immunotherapy in advanced hepatocellular carcinoma using a quantitative systems pharmacology model

Journal for ImmunoTherapy of Cancer(2022)10.1136/jitc-2022-005414

N/A

1.2DataRank · unranked

49 citations

Babita K. Verma, Hanwen Wang, Won Jin Ho, Mark Yarchoan, Aleksander S. Popel +1 more

Entinostat in combination with nivolumab in metastatic pancreatic ductal adenocarcinoma: a phase 2 clinical trial

Nature Communications(2024)10.1038/s41467-024-52528-7

N/A

1.0DataRank · unranked

42 citations

Ludmila Danilova, Jennifer N. Durham, Courtney B. Betts, Leslie Cope, Dimitrios N. Sidiropoulos +19 more

CD4 T cell–activating neoantigens enhance personalized cancer vaccine efficacy

JCI Insight(2023)10.1172/jci.insight.174027

N/A

0.921DataRank · unranked

34 citations

Gabriella Longway, Jacob T. Mitchell, Lalitya Andaloori, Emily F. Davis-Marcisak, Fangluo Chen +15 more

Four-year overall survival update from the phase III HIMALAYA study of tremelimumab plus durvalumab in unresectable hepatocellular carcinoma

Annals of Oncology(2024)10.1016/j.annonc.2024.02.005

N/A

0.868DataRank · unranked

326 citations

S.L. Chan, R.K. Kelley, G. Lau, M. Kudo, W. Sukeepaisarnjaroen +198 more

Immunotherapy response induces divergent tertiary lymphoid structure morphologies in hepatocellular carcinoma

Nature Immunology(2024)10.1038/s41590-024-01992-w

N/A

0.695DataRank · unranked

102 citations

Won Jin Ho, Luciane T. Kagohara, Alexander A. Girgis, Sarah M. Shin, Ludmila Danilova +34 more

Multi-omic profiling of lung and liver tumor microenvironments of metastatic pancreatic cancer reveals site-specific immune regulatory pathways

Genome biology(2021)10.1186/s13059-021-02363-6

N/A

0.631DataRank · unranked

66 citations

Rossin Erbe, Ludmila Danilova, Zaw Phyo, Emma Bigelow, Genevieve L. Stein-O’Brien +14 more

Viral status, immune microenvironment and immunological response to checkpoint inhibitors in hepatocellular carcinoma

Journal for ImmunoTherapy of Cancer(2020)10.1136/jitc-2019-000394

N/A

0.624DataRank · unranked

63 citations

Ludmila Danilova, Su Jin Lim, Rohan Verma, Stephanie Xavier, James M. Leatherman +6 more

Pan-tumor analysis to investigate the obesity paradox in immune checkpoint blockade

Journal for ImmunoTherapy of Cancer(2025)10.1136/jitc-2024-009734

N/A

0.574DataRank · unranked

18 citations

Soren Charmsaz, Howard L. Li, Hua‐Ling Tsai, Ludmila Danilova, Kabeer Munjal +29 more

Uncovering the spatial landscape of molecular interactions within the tumor microenvironment through latent spaces

Cell Systems(2023)10.1016/j.cels.2023.03.004

N/A

0.557DataRank · unranked

40 citations

Melanie Loth, Dimitrios N. Sidiropoulos, Shuming Zhang, Long Yuan, Alexander T.F. Bell +25 more

Integration of Clinical Trial Spatial Multiomics Analysis and Virtual Clinical Trials Enables Immunotherapy Response Prediction and Biomarker Discovery

Cancer Research(2024)10.1158/0008-5472.can-24-0943

N/A

0.546DataRank · unranked

37 citations

Atul Deshpande, Babita K. Verma, Hanwen Wang, Haoyang Mi, Long Yuan +9 more

Salvage Ipilimumab plus Nivolumab after Anti-PD-1/PD-L1 Therapy in Advanced Hepatocellular Carcinoma

Cancer Research Communications(2023)10.1158/2767-9764.crc-23-0072

N/A

0.529DataRank · unranked

33 citations

Mir Lim, Chester Kao, Daniel Shu, Amit G. Singal, Anne M. Noonan +7 more

Age-related divergence of circulating immune responses in patients with solid tumors treated with immune checkpoint inhibitors

Nature Communications(2025)10.1038/s41467-025-58512-z

N/A

0.510DataRank · unranked

29 citations

Soren Charmsaz, Hua‐Ling Tsai, Khaled Aziz, Daniel Shu, Kabeer Munjal +25 more

Immune-related events in individuals with solid tumors on immunotherapy associate with Th17 and Th2 signatures

Journal of Clinical Investigation(2024)10.1172/jci176567

N/A

0.500DataRank · unranked

27 citations

Soren Charmsaz, Stephanie Alden, Madelena Brancati, Howard L. Li, Aanika Balaji +38 more

Integrated immunological analysis of a successful conversion of locally advanced hepatocellular carcinoma to resectability with neoadjuvant therapy

Journal for ImmunoTherapy of Cancer(2020)10.1136/jitc-2020-000932

N/A

0.483DataRank · unranked

24 citations

Gaurav Sharma, Qingfeng Zhu, Genevieve L. Stein-O’Brien, Jennifer N. Durham, Robert A. Anders +8 more

Protein synthesis inhibitor omacetaxine is effective against hepatocellular carcinoma

JCI Insight(2021)10.1172/jci.insight.138197

N/A

0.483DataRank · unranked

24 citations

Gilad Halpert, Michael G. Lerner, Hai‐Jie Hu, Peter Dimitrion, Matthew J. Weiss +17 more

Immune landscape of tertiary lymphoid structures in hepatocellular carcinoma (HCC) treated with neoadjuvant immune checkpoint blockade

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.10.16.562104

N/A

0.434DataRank · unranked

17 citations

Won Jin Ho, Luciane T. Kagohara, Alexander A. Girgis, Sarah M. Shin, Ludmila Danilova +29 more

A therapeutic peptide vaccine for fibrolamellar hepatocellular carcinoma: a phase 1 trial

Nature Medicine(2025)10.1038/s41591-025-03995-y

N/A

0.302DataRank · unranked

6 citations

Allison M. Kirk, Brian H. Ladle, Zeal Kamdar, Kayla J. Bendinelli, Won Jin Ho +23 more

ETCTN 10476: A randomized phase 2 study of combination atezolizumab and varlilumab (CDX-1127) with or without addition of cobimetinib in previously treated unresectable biliary tract cancer.

Journal of Clinical Oncology(2023)10.1200/jco.2023.41.4_suppl.tps639

N/A

0.230DataRank · unranked

3 citations

Mark Yarchoan, Judy Murray, Hao Wang, John Joseph Wright, Elad Sharon +3 more

Molecular Evidence of Multiorgan Damage in Patients with Immune-Related Adverse Events

New England Journal of Medicine(2025)10.1056/nejmc2513984

N/A

0.208DataRank · unranked

3 citations

Howard L. Li, Chetan Bettegowda, Kenneth W. Kinzler, Nickolas Papadopoulos, Mark Yarchoan +2 more

Liver fibrosis uncouples tumor control from survival after multikinase inhibitor immunotherapy in hepatocellular carcinoma

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.10.20.563378

N/A

0.165DataRank · unranked

2 citations

Hiroto Kikuchi, Atsuyo Morita, Tatsuya Kobayashi, Grace Birch, Zhiping Ruan +14 more

Informing virtual clinical trials of hepatocellular carcinoma with spatial multi-omics analysis of a human neoadjuvant immunotherapy clinical trial

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.08.11.553000

N/A

0DataRank · unranked

6 citations

Atul Deshpande, Babita K. Verma, Hanwen Wang, Hao‐Yang Mi, Long Yuan +9 more

Critical Appraisal of Guideline Recommendations on Systemic Therapies for Advanced Hepatocellular Carcinoma

JAMA Oncology(2023)10.1001/jamaoncol.2023.2677

N/A

0DataRank · unranked

151 citations

Virginia Corbett, Mark Yarchoan, Richard S. Finn, Josep M. Llovet, Sarah Cappuyns

Tumor Mutational Burden, Toxicity, and Response of Immune Checkpoint Inhibitors Targeting PD(L)1, CTLA-4, and Combination: A Meta-regression Analysis

Clinical Cancer Research(2020)10.1158/1078-0432.ccr-20-0458

N/A

0DataRank · unranked

109 citations

Su Jin Lim, Aleksandra Popović, Nilofer S. Azad, Daniel A. Laheru, Lei Zheng +4 more

Data from Salvage Ipilimumab plus Nivolumab after Anti-PD-1/PD-L1 Therapy in Advanced Hepatocellular Carcinoma

(2023)10.1158/2767-9764.c.6719612.v2

N/A

0DataRank · unranked

0 citations

Mir Lim, Chester Kao, Daniel Shu, Amit G. Singal, Anne M. Noonan +7 more

Adjuvant and neoadjuvant immunotherapies in hepatocellular carcinoma

Nature Reviews Clinical Oncology(2024)10.1038/s41571-024-00868-0

N/A

0DataRank · unranked

346 citations

Roser Pinyol, Mark Yarchoan, Amit G. Singal, Thomas U. Marron, Myron E. Schwartz +4 more

Neoadjuvant immune checkpoint blockade: A window of opportunity to advance cancer immunotherapy

Cancer Cell(2023)10.1016/j.ccell.2023.07.011

N/A

0DataRank · unranked

288 citations

Patrick M. Forde, Leisha A. Emens, Mark Yarchoan, Kellie N. Smith, Drew M. Pardoll +1 more

Combined MEK/PD-L1 Inhibition Alters Peripheral Cytokines and Lymphocyte Populations Correlating with Improved Clinical Outcomes in Advanced Biliary Tract Cancer

Clinical Cancer Research(2022)10.1158/1078-0432.ccr-22-1123

N/A

0DataRank · unranked

13 citations

Mark Yarchoan, Subir Goyal, Yuan Liu, Elad Sharon, Helen X. Chen +7 more

Solid Organ Transplantation Is Associated with an Increased Rate of Mismatch Repair Deficiency and PIK3CA Mutations in Colorectal Cancer

Current Oncology(2022)10.3390/curroncol30010006

N/A

0DataRank · unranked

8 citations

Valerie Lee, Hao Wang, Mark Yarchoan, Ana De Jesus‐Acosta, Nilo Azad +7 more

Integrated T cell cytometry metrics for immune-monitoring applications in immunotherapy clinical trials

JCI Insight(2022)10.1172/jci.insight.160398

N/A

0DataRank · unranked

17 citations

Genevieve L. Stein-O’Brien, Ludmila Danilova, Nicole Groß, Soren Charmsaz, Stephanie Xavier +7 more

Targeting BCL-XL in fibrolamellar hepatocellular carcinoma

JCI Insight(2022)10.1172/jci.insight.161820

N/A

0DataRank · unranked

27 citations

Denise Ng, Gadi Lalazar, Carly Rosemore, Tova M. Finkelstein, Rachael D. Migler +13 more

Investigating peripheral blood biomarkers of immune checkpoint inhibitor associated fatigue.

Journal of Clinical Oncology(2024)10.1200/jco.2024.42.16_suppl.2571

N/A

0DataRank · unranked

0 citations

Soren Charmsaz, Stephanie Alden, Madelena Brancati, Aanika Warner, Kabeer Munjal +15 more

Multi-Scale Spatial Analysis of the Tumor Microenvironment Reveals Features of Cabozantinib and Nivolumab Efficacy in Hepatocellular Carcinoma

Frontiers in Immunology(2022)10.3389/fimmu.2022.892250

N/A

0DataRank · unranked

89 citations

Won Jin Ho, Mark Yarchoan, Aleksander S. Popel, Haoyang Mi

825 High-dimensional image cytometry reveals spatially organized tumor-immune microenvironment in hepatocellular carcinoma

Regular and Young Investigator Award Abstracts(2021)10.1136/jitc-2021-sitc2021.825

N/A

0DataRank · unranked

1 citations

Won Jin Ho, Mark Yarchoan, Aleksander S. Popel, Hao‐Yang Mi

Feasibility and efficacy of neoadjuvant cabozantinib and nivolumab in patients with borderline resectable or locally advanced hepatocellular carcinoma (HCC).

Journal of Clinical Oncology(2021)10.1200/jco.2021.39.3_suppl.335

N/A

0DataRank · unranked

22 citations

Qingfeng Zhu, Jennifer N. Durham, Nicole Groß, Soren Charmsaz, James M. Leatherman +14 more

Anti-CTLA4 Therapy Leads to Early Expansion of a Peripheral Th17 Population and Induction of Th1 Cytokines

Cancer Immunology Research(2025)10.1158/2326-6066.cir-24-1055

N/A

0DataRank · unranked

6 citations

Soren Charmsaz, Elsa Hallab, Mike Fang, Chester Kao, Madelena Brancati +19 more

Consensus-based disease definitions for endocrine immune-related adverse events of immune checkpoint inhibitors

Journal for ImmunoTherapy of Cancer(2025)10.1136/jitc-2025-011865

N/A

0DataRank · unranked

5 citations

Yee-Ming Melody Cheung, Cherie Chiang, Emily J. Gallagher, Ole‐Petter R. Hamnvik, Jennifer S. Mammen +32 more

Rapidly progressive metastatic cholangiocarcinoma in a postpartum patient with cystic fibrosis: a case report

BMC Pulmonary Medicine(2020)10.1186/s12890-020-01337-x

N/A

0DataRank · unranked

5 citations

Kelly E. Craven, David W. Nauen, Kristina Montemayor, Mark Yarchoan, William R. Burns +3 more

DNAJ-PKAc induces metabolic rewiring and enhanced glutamine flux in fibrolamellar HCC

Journal of Hepatology(2025)10.1016/j.jhep.2025.10.027

N/A

0DataRank · unranked

1 citations

Elisete Mariane Neumann, Kathryn L. Howe, Donald Long, Waqar Arif, Daniel H. Shu +22 more

Effects of B cell–activating factor on tumor immunity

JCI Insight(2020)10.1172/jci.insight.136417

N/A

0DataRank · unranked

53 citations

Won Jin Ho, Aditya Mohan, Yajas Shah, Teena Vithayathil, James M. Leatherman +8 more